![]() |
市場調查報告書
商品編碼
1801192
2025 年至 2033 年攜帶式製氧機市場規模、佔有率、趨勢及預測(按技術、應用、最終用戶和地區)Portable Oxygen Concentrators Market Size, Share, Trends and Forecast by Technology, Application, End User, and Region, 2025-2033 |
2024年,全球攜帶式製氧機市場規模達19億美元。展望未來, IMARC Group預測,到2033年,該市場規模將達到35億美元,2025年至2033年期間的複合年成長率為6.97%。目前,北美佔據市場主導地位,2024年其市佔率將超過38.9%。推動市場發展的主要因素包括慢性阻塞性肺病、氣喘和囊性纖維化等呼吸系統疾病病例的增加、老年人口的增加以及人們對居家醫療的日益青睞。
肺氣腫和慢性阻塞性肺病 (COPD) 等呼吸系統疾病的發生率不斷上升,推動了攜帶式製氧機 (POC) 市場的發展。隨著年齡的成長,越來越多的人更容易患上慢性呼吸系統疾病。攜帶式製氧機技術也取得了進步,其效率更高、電池壽命更長,設計更輕巧緊湊,滿足了用戶在接受治療時對移動性和獨立性的需求。市場趨勢反映出,人們越來越傾向於選擇居家照護解決方案,因為與住院治療相比,居家照護方案更具成本效益且更便利。這種轉變促使製造商不斷創新 POC,以滿足患者的特定需求。此外,醫療保健基礎設施的改善和氧氣治療宣傳項目的推廣,也推動了攜帶式設備在新興市場的普及。隨著數位醫療工具的日益普及,智慧技術的整合,包括與行動應用程式的連接以實現遠端監控和調整,也正在蓬勃發展。此外,已開發國家政府為醫療器材提供補貼和報銷的措施也改善了市場准入。這些促進因素和趨勢共同強調了市場向先進、方便用戶使用且易於使用的攜帶式氧氣濃縮器的方向發展。
美國已成為攜帶式製氧機的重要區域市場。由於人口老化和環境因素的影響,慢性阻塞性肺病 (COPD) 和氣喘等呼吸系統疾病的發生率不斷上升,美國攜帶式製氧機市場正在蓬勃發展。醫療支出的增加以及患者對居家護理的偏好,加速了攜帶式設備的普及,為氧氣治療提供了便利性和移動性。輕量化設計、超長電池續航力以及應用程式連接等智慧功能等技術創新正在塑造市場趨勢。此外,政府支持醫療保險報銷的政策也擴大了這些設備的使用範圍。隨著價值導向護理模式和個人化治療的興起,越來越多的患者需要這種先進的、以使用者為中心的製氧機。人們對呼吸健康的關注度不斷提高,以及對改善生活品質的渴望日益成長,也對市場的發展起到了積極作用。
呼吸系統疾病病例增加
越來越多的患者被診斷出患有肺癌、慢性阻塞性肺病 (COPD)、氣喘、肺纖維化和流感等呼吸系統疾病,他們需要高效的氧氣治療系統。根據世界衛生組織 (WHO) 報告,估計全球有 5.45 億人患有慢性呼吸系統疾病,包括 COPD、氣喘和肺纖維化,因此氧氣治療需求構成了龐大的潛在患者群體。攜帶式氧氣治療 (POC) 為患者提供便捷的攜帶式氧氣輸送,使其能夠護理自身病情並改善整體生活品質。呼吸系統疾病發生率的上升推動了市場對 POC 的需求。此外,POC 還允許醫護人員在家中提供護理,從而在醫院外提供醫療服務,從而減輕醫院的負擔。此外,與其他傳統的氧氣治療方法相比,POC 也是一種低成本的選擇,因為無需頻繁補充氧氣瓶或維護固定式製氧機。
家庭醫療保健需求不斷成長
隨著家庭醫療保健需求的日益成長,醫療設備在治療時對便攜性的需求也隨之成長。 POC 恰好滿足了這一需求,因為它能夠輕鬆便捷地在家中進行氧氣治療。根據歐洲呼吸學會 2022 年的數據顯示,60% 的慢性呼吸道疾病患者更傾向於在家中接受護理,而非在醫院接受治療,其主要原因是便利性和舒適性。隨著居家照護趨勢的日益成長,攜帶式製氧機的需求也達到了頂峰。此外,居家醫療保健可以透過減少住院時間、再入院率和急診就診次數來節省醫療系統的成本。 POC 允許患者在家中接受氧氣治療,從而降低因呼吸系統疾病入院的可能性。醫療資源的最佳化和成本效益的提升推動了 POC 融入居家照護策略的進程。
老年人口不斷增加
隨著年齡的成長,人們罹患慢性阻塞性肺病、肺炎和其他肺部疾病等呼吸系統疾病的可能性也隨之增加。這些疾病通常需要長期氧氣治療來緩解症狀並提高生活品質。老年人口的增加直接導致了呼吸系統疾病的盛行率上升。因此,作為氧氣治療的必需醫療設備,攜帶式氧氣治療儀 (POC) 的需求日益成長。例如,根據歐盟委員會的數據,2023 年歐洲老年人口數量也大幅增加。該地區 65 歲以上的老年人佔總人口的 21.3% 以上。此外,POC 還具備移動性和便攜性,使老年人能夠積極地生活和維持其生活方式,並獲得必要的氧氣供應。老年人群體對積極老化的渴望推動了對攜帶式氧氣治療儀的需求,使他們能夠充分參與自己喜歡的活動。
The global portable oxygen concentrators market size was valued at USD 1.9 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 3.5 Billion by 2033, exhibiting a CAGR of 6.97% from 2025-2033. North America currently dominates the market, holding a significant market share of over 38.9% in 2024. The major factors driving the market are the rising cases of respiratory diseases such as chronic obstructive pulmonary disease, asthma, and cystic fibrosis, rising geriatric population and growing affinity for home-based medical treatment.
The growing incidence of respiratory conditions like emphysema and chronic obstructive pulmonary disease (COPD) is propelling the market for portable oxygen concentrators (POCs). With age, more people are becoming vulnerable to chronic respiratory issues. The portable oxygen concentrator technology has also seen its advancements with regards to increased efficiency with longer battery life and reduced and lighter designs that increase user appeal for the need for mobility and independence while receiving treatment. Market trends reflect increased preference toward home-based care solutions since they are cost-effective and convenient as opposed to a hospital stay. This shift has prompted the manufacturers to innovate POCs to meet patient-specific needs. In addition, the increasing adoption of portable devices in the emerging market is backed up by improved healthcare infrastructure and the spreading of awareness programs for oxygen therapy. The integration of smart technologies, including connectivity to mobile applications for remote monitoring and adjustment, is gaining momentum in tandem with the increasing adoption of digital health tools. Additionally, government initiatives that provide subsidies and reimbursements for medical devices in developed countries improve market access. These drivers and trends collectively underscore the market's direction toward advanced, user-friendly, and accessible portable oxygen concentrators.
The United States has emerged as a key regional market for portable oxygen concentrators. The United States portable oxygen concentrators market is growing due to the increasing prevalence of respiratory conditions like COPD and asthma, driven by aging demographics and environmental factors. Increasing healthcare spending and patient preference for home-based care are accelerating the adoption of portable devices, offering convenience and mobility for oxygen therapy. Technological innovations including lightweight designs, extra-long battery life, and smart features like app connectivity are molding the market trends. Further, the government policies supporting Medicare reimbursement have widened access to these devices. With the value-based care model and personalized treatment, more patients need such advanced, user-oriented concentrators. Higher consciousness toward respiratory health and increasing desire for a better quality of patients' lives are also positive contributors to the market.
Increasing cases of respiratory conditions
The increasing cases of patients diagnosed with respiratory conditions such as lung cancer, COPD, asthma, pulmonary fibrosis, and flu require an efficient oxygen therapy system. As reported by WHO, it is estimated that 545 million people suffer from chronic respiratory diseases, including COPD, asthma, and pulmonary fibrosis, thus forming a vast potential patient base for the requirement of oxygen therapy. POCs provide convenient and portable oxygen delivery to patients with the ability to care for their conditions and improve their overall quality of life. Increases in respiratory disease incidence rates account for the growth in POC demand in the market. Additionally, POCs allow healthcare providers to administer care outside the walls of the hospital by delivering care in the home thus alleviating the burden on the hospitals. In addition, POCs also are a low-cost option as compared with other conventional oxygen therapy methods where frequent refills of cylinders or maintenance of stationary concentrators are done away with.
Growing demand for home medical care
The increasing need for home medical care grows the demand to have portability in medical devices at the time of treatment. POCs fit well within this need as they allow for the easy and portable use of oxygen therapy within a home setting. According to the European Respiratory Society, in 2022 it was revealed that 60% of patients with chronic respiratory diseases prefer to be cared for at home rather than within a hospital, citing convenience and comfort as major factors. With this growing trend toward care at home, the increasing need for portable oxygen concentrators is at its peak. In addition, home-based medical care can potentially save healthcare systems money in terms of decreasing hospital stays, readmissions, and emergency department visits. POCs allow patients to receive oxygen therapy at home, which reduces the likelihood of being admitted to a hospital due to respiratory disease. Optimization of healthcare resources and cost-effectiveness drive the integration of POCs into home-based care strategies.
Increasing geriatric population
As people age, their susceptibility to respiratory diseases such as chronic obstructive pulmonary disease, pneumonia, and other lung disorders increases. These conditions typically require long-term oxygen therapy to alleviate symptoms and enhance the quality of life. The increasing geriatric population directly contributes to the increased prevalence of respiratory diseases. As a result, POCs are in greater demand as a necessary medical device for oxygen therapy. For example, according to the European Commission, the number of elderly increased dramatically in Europe in 2023 as well. More than 21.3% of people above 65 years made up the entire population in that region. Also, POCs ensure mobility and portability that enables elderly people to live actively and carry on with their lifestyles, and in doing so, receive the necessary oxygen supply. The aspiration for active aging by the geriatric population fuels the demand for POCs that enable them to participate fully in their desired activities.
In 2024, pulse flow represents the leading segment with 69.5% of the portable oxygen concentrators market share. The delivery of oxygen makes an oxygen flow that would go synchronized with breathing by a patient, with low oxygen wastage that contributes to higher usability of this type of technology, valued because of its lightweight design that contributes to portability. It is suitable for active patients requiring mobility during oxygen therapy. This segment has been further strengthened by innovations such as longer battery life, compact form factors, and advanced sensors that adapt to varying respiratory patterns. Pulse flow devices cater to the growing preference for home-based care and ambulatory use, especially among individuals with chronic respiratory conditions. Moreover, the integration of smart features, including app-based monitoring and real-time adjustments, has elevated user experience and encouraged adoption. The increasing prevalence of chronic respiratory diseases, coupled with technological advancements and awareness about portable oxygen solutions, continues to propel this segment's growth and reinforce its market leadership.
COPD dominates the segment and holds a 43.2% market share since this chronic condition has a high prevalence globally. As a result, patients using COPD often require supplemental oxygen therapy for the elongated periods to control and improve their quality of life. The portable oxygen concentrators will be of great importance, as these patients cannot use an oxygen tank for mobility since it has limited space. The aging population, more vulnerable to COPD, is a prime growth driver for this market. Increased awareness campaigns of the importance of early diagnosis and treatment are also contributing to wider adoption. The device manufacturers are tailoring products to meet COPD-specific needs, integrating features such as adjustable oxygen flow rates, extended operating times, and lightweight designs. In addition, the trend toward affordable, home-based care options has increased demand for portable oxygen concentrators among COPD patients.
Ambulatory surgery centers hold the largest market share, which is an emerging trend toward outpatient care as it is more cost-effective and convenient. The centers often use portable oxygen concentrators for pre-operative and post-operative respiratory support in patients with chronic underlying conditions, such as COPD. The portability and mobility of these devices are best suited for ASCs where space and efficiency are critical. The growth in the number of ASCs and the trend toward delivering high-quality care in shorter patient stays have played a significant role in ASC dominance. Portable concentrators allow for faster patient recovery and turnover, which meets the operational needs of an ASC. There is an increasing trend toward minimally invasive procedures, which require oxygen support for respiratory stability, increasing demand. Technological improvements through compact designs and user-friendly interfaces enhance adoption. With healthcare trends being set in favor of outpatient settings versus traditional hospital care, portable oxygen concentrators in the ASC continue to gain relevance and establish further leadership within this segment.
In 2024, North America held the largest portable oxygen concentrators market share with 38.9%. North America hosts a high prevalence of respiratory diseases, including COPD, asthma, and other lung conditions. The region's demographic aging, environmental factors, and lifestyle choices contribute to higher rates of respiratory conditions. The higher incidence rate of such diseases leads to the creation of a larger patient group, who require oxygen therapy in the given region. Therefore, there will be a hike in demand for POCs in North America. Also, the region houses well-established healthcare infrastructure, especially high-quality medical facilities, a better health system, and the required funds for healthcare-related research and development. A superior class of hospitals, clinics, and ambulatory surgery centers provide an enhanced platform for the acceptance of POCs. Moreover, the POC market experienced relentless technological advancements, during which North America was always at the forefront of those developments. The region has several key players in the health care and medical device industry which creates a culture of research and development.
The Asia Pacific portable oxygen concentrators market is growing due to the prevalence of respiratory disease and the graying population across the region. Rapid urbanization leads to increased levels of air pollutants, which creates a greater incidence of COPD and asthma, boosting demand. Additionally, the rapid development of the health infrastructure and improving awareness about the use of oxygen therapy propel this market growth. The most important drivers in this region are government initiatives to enhance access to medical devices, as well as the growing popularity of homecare solutions, particularly in emerging markets such as China and India.
The European portable oxygen concentrators market is driven by a high prevalence of chronic respiratory conditions and a growing elderly population. Increasing awareness about early diagnosis and oxygen therapy encourages adoption. The expansion of the market is also supported by favorable reimbursement policies across countries such as Germany, France, and the UK. Technological advancements in medical devices and the region's focus on home-based care solutions further increase demand. Furthermore, increasing healthcare expenditure and the drive to promote respiratory health are pushing the market, with a growing emphasis on patient-centric, portable healthcare solutions.
The market for portable oxygen concentrators in Latin America is increasing as respiratory diseases, including COPD and asthma, continue to rise because of pollution and smoking rates. The economies of countries like Brazil and Mexico have improved healthcare accessibility and affordability, increasing the demand for sophisticated medical equipment. Increased awareness campaigns and acceptance of homecare oxygen therapy have become crucial factors. In addition, investments in healthcare infrastructure and the increasing availability of compact, cost-effective portable concentrators are further supporting market growth in the region.
The market is growing in the Middle East and Africa due to increased awareness about respiratory health and a growing prevalence of conditions such as asthma and COPD. Main Enablers of Improvement in Healthcare Infrastructure and Economic Development, particularly in Countries like UAE and South Africa Adoption of Home-Based Oxygen Therapy Solutions, with Help from the Governments to Improve Medical Devices and Further Enhanced Availability due to Increased Partnering with International Manufacturers as Well as Local Distributors Across This Region.
United States Portable Oxygen Concentrators Market Analysis
The United States accounts for 80% of the portable oxygen concentrators market in North America. Advanced healthcare infrastructure and high prevalence of chronic respiratory conditions help the U.S. portable oxygen concentrators market. The Centers for Disease Control and Prevention (CDC) reported that around 16 million Americans have chronic obstructive pulmonary disease (COPD), leading to demand for oxygen therapy devices. Medicare reimbursement policies also enhance affordability and adoption. Market leaders like Inogen and Invacare drive the market through technological innovation in lightweight, battery-powered models. Awareness about respiratory health and government support for homecare solutions are the other factors driving growth. Canada and Mexico export opportunities increase the U.S. share as an important international player in the global market for portable oxygen concentrators.
Europe Portable Oxygen Concentrators Market Analysis
The growth of the European market for portable oxygen concentrators is closely related to both the growing demand for long-term oxygen therapy and the changing clinical practices that are increasingly based on individualized care. According to the 2023 European Lung Foundation report, many people in Europe use long-term oxygen therapy, thus directly creating a need for portable devices. This is in line with the trend of individualizing oxygen prescriptions that have emerged in clinical practice and are widely done in countries such as Italy, France, and the Netherlands. For example, according to the European Respiratory Society, in Italy, 67% of respirologists screen patients at night to tailor nocturnal prescriptions, a practice also reflected in the increased use of portable oxygen devices. The strategy is an even more significant trend toward personalization of treatment, to which the growth of e-commerce sites such as Amazon and Mediq, providing greater access to patients, contributes. Moreover, more aggressive goals for Sa, O2 levels, such as the 35% in Spain and 36% in Italy targeting >=92%, are linked to the enhanced complexity of portable oxygen concentrators, which are intended to be more patient-specific. This is part of the USD 36 Billion in medical devices allocated in Germany's 2022 healthcare budget, clearly reflecting investment in respiratory care equipment, including portable oxygen concentrators. The demand for this is supported by regulatory standards and public health awareness campaigns, so ensuring that both safety and accessibility gains the trust of patients in the devices. This correlation between the growing number of respiratory illness cases, individualized oxygen prescriptions, and innovation in portable oxygen technology is driving the growth of the market in Europe.
Asia Pacific Portable Oxygen Concentrators Market Analysis
The Asia Pacific portable oxygen concentrator market is expanding significantly as a result of rising healthcare costs and the high incidence of respiratory illnesses. The WHO estimates that more than 100 million in China suffer from COPD, which leads to demand for oxygen therapy equipment. The Chinese government allocated a sum of 1.5 Billion USD toward medical equipment during the year 2023 as part of its medical reform. Making in India-India has motivated domestic production, reduced costs, and increased availability. Panasonic, one of the Japanese major manufacturers, is now releasing premium models with innovative features to satisfy the needs of technology-conscious customers. Additionally, the association between global companies and local distributors allows the product to access a wider range of consumers. Malaysia and Thailand are now increasingly witnessing medical tourism, thereby increasing the demand for portable oxygen concentrators. Tie-ups between global companies and local distributors also ensure that the product reaches more consumers.
Latin America Portable Oxygen Concentrators Market Analysis
The portable oxygen concentrators market is emerging in Latin America due to rising healthcare investment and the prevalence of respiratory diseases in the region. International Trade Government cited Brazil as the largest healthcare market in this region as it spent 9.47% of its GDP on healthcare. This high investment boosts access to modern medical devices, which in this case includes an oxygen concentrator. The International Pharmaceutical Federation reports that over 6.3 million people in Brazil suffer from COPD and this amounts to a huge market for portable oxygen therapy. Government initiatives like Mexico's Seguro Popular offer subsidies to increase the adoption rates within the region. This encourages big players like Philips and GCE Group to launch energy-efficient models that are affordable to meet regional needs. Latin America will be a growth region for portable oxygen concentrators, with increasing market demand due to an improving healthcare infrastructure and rising demand for home healthcare services.
Middle East and Africa Portable Oxygen Concentrators Market Analysis
The increased incidence rates of respiratory ailments and the interest by the governments to improve health care drive the demand for portable oxygen concentrators across the Middle East and Africa. The International Respiratory Foundation puts the regional prevalence of the entire patient population with COPD to be more than 6 Million. Saudi Arabia dedicated USD 5 Billion in 2023 for health sector modernization in purchasing oxygen concentrators and other health products within Vision 2030. One of South Africa's home-based manufacturers is Afrox. They provide patients with home-based medical products very reasonably. The rise of home care products in the cities of Egypt and the United Arab Emirates is leading to a boost in demand. Strategic collaborations with overseas producers are making products more available and affordable and therefore spur growth in the regional market.
Key players are emphasizing innovation and strategic plans as they look to meet increased demands for efficient and user-friendly devices. The key companies in the portable oxygen concentrator industry are investing substantially in research and development. Technologically advanced products would feature extended battery life, greater portability, and the use of smart technologies such as Bluetooth connectivity and mobile app monitoring. One important trend, that involves a lot of partnerships and collaboration, is where companies form agreements to bolster their networks, expand their presence, and push into worldwide markets. As is the case with players like several being aligned to providers for smooth availability in healthcare systems, home care service providers for easy use, and awareness about adoption, among other combinations. It is through merger and acquisition wherein companies continue strengthening their offerings and geographical markets. In regions such as North America and Europe, which are highly regulated, companies are focusing on obtaining regulatory approvals and certifications to comply with healthcare standards. Most companies are also targeting emerging markets by offering cost-effective solutions to budget-conscious consumers. The combination of innovation, strategic alliances, and geographic expansion underscores the proactive approach of market players to capitalize on the increasing demand for portable oxygen concentrators.